Using a novel animal model of the dopaminergic dysfunction of schizophrenia to trial an innovative treatment approach

Project Information

EDiPSPrevent

Grant agreement ID: 101028661

DOI

10.3030/101028661

Project closed

EC signature date 7 April 2021

Start date 31 January 2022

End date 30 January 2024

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 212 933,76

EU contribution

€ 212 933,76

Coordinated by

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study

Author(s): Alice Petty, Anna Garcia-Hidalgo, Els F Halff, Sridhar Natesan, Dominic J Withers, Elaine E Irvine, Michelle Kokkinou, Lisa A Wells, David R Bonsall, Sac-Pham Tang, Mattia Veronese, Oliver D Howes1,2,3,8,9
Published in: Molecular Imaging and Biology, 2023, ISSN 1536-1632
Publisher: Elsevier BV
DOI: 10.1007/s11307-023-01865-y